EDGAR Filing Documents for 0001493152-18-014063

Form 8-K - Current report:

SEC Accession No. 0001493152-18-014063

Filing Date

2018-10-04

Accepted

2018-10-03 20:39:47

Documents

Period of Report

2018-10-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	39563
2		ex10-1.htm	EX-10.1	103016
3		ex10-2.htm	EX-10.2	138827
4		ex10-3.htm	EX-10.3	75151
	Complete submission text file	0001493152-18-014063.txt		357849

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801

Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 215-988-0080

HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)